FCM
ACIU icon

Farallon Capital Management’s AC Immune ACIU Stock Holding History

Farallon Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,000
Closed -$247K – 72
2016
Q3 		$247K Buy
+15,000
New +$259K ﹤0.01% 67

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Farallon Capital Management's ACIU Position: Q4 2016 in Review

Farallon Capital Management sold out of AC Immune (ACIU) in Q4 2016, closing a stake of 15,000 shares — an estimated $247K sold.

Farallon Capital Management first reported a position in ACIU in Q3 2016 and held it in 1 quarter. The position peaked at $247K in Q3 2016. 19 funds tracked by Wall St. Rank hold ACIU as of Q4 2016.

  • Farallon Capital Management reported no remaining AC Immune position as of Q4 2016 after selling out during the quarter.
  • Farallon Capital Management sold 15,000 AC Immune shares in Q4 2016, an estimated $247K.
  • Farallon Capital Management first reported a position in AC Immune in Q3 2016 and held it in 1 quarter.
  • Farallon Capital Management's AC Immune position peaked at $247K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held AC Immune as of Q4 2016.

Based on Farallon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.